UBS Group
CLX icon

UBS Group’s Clorox CLX Stock Holding History

UBS Group’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,000
Closed -$141K – 10398
2022
Q2 		$141K Buy
1,000
+500
+100% +$71.4K ﹤0.01% 5171
2022
Q1 		$70K Sell
500
-200
-29% -$30.6K ﹤0.01% 6169
2021
Q4 		$122K Hold
700
– – ﹤0.01% 6117
2021
Q3 		$116K Buy
700
+200
+40% +$34.4K ﹤0.01% 5727
2021
Q2 		$90K Hold
500
– – ﹤0.01% 5960
2021
Q1 		$96K Sell
500
-24,600
-98% -$4.74M ﹤0.01% 5995
2020
Q4 		$5.07M Buy
25,100
+15,500
+161% +$3.21M ﹤0.01% 2438
2020
Q3 		$2.02M Buy
+9,600
New +$2.14M ﹤0.01% 3028
2018
Q2 		– Sell
-2,000
Closed -$266K – 8004
2018
Q1 		$266K Hold
2,000
– – ﹤0.01% 4591
2017
Q4 		$297K Buy
+2,000
New +$272K ﹤0.01% 4647
2017
Q3 		– Sell
-2,600
Closed -$346K – 7741
2017
Q2 		$346K Buy
2,600
+200
+8% +$27K ﹤0.01% 4385
2017
Q1 		$323K Buy
2,400
+600
+33% +$77.7K ﹤0.01% 4333
2016
Q4 		$216K Buy
1,800
+1,600
+800% +$189K ﹤0.01% 4737
2016
Q3 		$25K Buy
+200
New +$26.2K ﹤0.01% 6090
2016
Q2 		– Sell
-500
Closed -$63K – 7745
2016
Q1 		$63K Sell
500
-100
-17% -$12.7K ﹤0.01% 5313
2015
Q4 		$76K Buy
600
+500
+500% +$62.1K ﹤0.01% 5434
2015
Q3 		$12K Sell
100
-600
-86% -$67.4K ﹤0.01% 7139
2015
Q2 		$72K Hold
700
– – ﹤0.01% 5669
2015
Q1 		$77K Sell
700
-900
-56% -$97.7K ﹤0.01% 5637
2014
Q4 		$167K Buy
+1,600
New +$160K ﹤0.01% 5212

Other funds holding CLX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

UBS Group's CLX Position: Q1 2026 in Review

UBS Group increased its Clorox (CLX) stake by 7.5% in Q1 2026, buying an estimated $7.2M and bringing the position to 914,364 shares worth $94.8M. The position accounts for 0.01% of the portfolio, ranked #1098.

UBS Group first reported a position in CLX in Q4 2014 and has held it in 46 quarters since. The position peaked at $216M in Q2 2025. 1,080 funds tracked by Wall St. Rank hold CLX as of Q1 2026.

  • UBS Group held 914,364 shares of Clorox worth $94.8M as of Q1 2026.
  • UBS Group bought 63,550 Clorox shares in Q1 2026, an estimated $7.2M.
  • Clorox made up 0.01% of UBS Group's portfolio in Q1 2026, its #1098 holding.
  • UBS Group first reported a position in Clorox in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's Clorox position peaked at $216M in Q2 2025.
  • 1,080 funds tracked by Wall St. Rank held Clorox as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.